Benjamin Dälken

The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells <i>In vitro</i> and <i>In vivo</i>

Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti et al. · Clinical Cancer Research · 2009 · 204 citations · Full text

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

Tobias Welte, R. Phillip Dellinger, Henning Ebelt et al. · Intensive Care Medicine · 2018 · 132 citations · Full text

Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition

Benjamin Dälken, Ulrike Giesübel, Shirley K. Knauer et al. · Cell Death and Differentiation · 2005 · 65 citations · Full text

Growth Factor, Cell Recognition, Apoptosis +10

A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway

Bianca Helling, Martin König, Benjamin Dälken et al. · Immunology and Cell Biology · 2014 · 37 citations · Full text

Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial

Eliézer K. N’Goran, Maurice R. Odiere, Ronald Assandé Aka et al. · The Lancet Infectious Diseases · 2023 · 33 citations

Malaria, Côte D'ivoire, Pediatrics +5